Diversity as the Master Metric
If the microbiome field has a master metric, it is diversity — and the landmark finding that low-richness guts cluster in less healthy people made it famous. This page explains what the number actually counts, walks the studies that built its reputation, and then spends equal time on the part most coverage skips: why diversity is a correlate with no reference range, and what that means for anyone tempted to test, track, or optimize it.
What the evidence supports
- Low gene count — a proxy for low species richness — clustered in people with more adiposity, insulin resistance, and inflammatory markers (Le Chatelier et al., Nature, 2013).
- Population cohorts consistently link higher richness with healthier diets and lower medication load (Zhernakova et al., Science, 2016; Falony et al., Science, 2016).
- Non-industrialized populations carry higher gut richness than Western ones, a finding replicated across continents (De Filippo et al., 2010; Smits et al., 2017).
What remains uncertain
- Diversity is a correlate, not a validated clinical target — no trial has shown that raising a diversity score by itself changes hard outcomes.
- There is no reference range for "healthy diversity"; values depend on diet, drugs, transit time, and the lab's method.
- Direction of causation is unresolved: healthier people may simply eat and live in ways that support richer ecosystems.
Evidence last reviewed: August 15, 2026. Conclusions may change as new research is published.
the diversity measure
What the Metric Actually Counts
"Diversity" sounds like one number, but ecologists measure it several ways, and each answers a slightly different question. The main ones:
| 📐 Metric | What it counts | What it misses | Verdict |
|---|---|---|---|
| Observed species | The number of different species detected (richness) | Ignores how evenly individuals are spread across species | Coarse |
| Shannon index | Richness combined with evenness in a single number | Collapses two distinct properties into one | Standard |
| Faith's phylogenetic diversity | Total branch length of the species' family tree | Depends on how the tree is built | Niche |
| Beta diversity | How different two samples are from each other | Needs a comparison set to mean anything | Standard |
In practice, when a headline says "diversity," it usually means alpha diversity — the richness of one sample — reported as the Shannon index or as a raw species count. When a commercial test reports "your diversity is in the 63rd percentile," that is Shannon-like math against the company's own customer database, which is worth remembering later on this page.
The Landmark Study
The study that made diversity famous is Le Chatelier et al. (Nature, 2013), which sequenced 292 Danish adults and split them by gene count — a DNA-level proxy for species richness. About 23% of the cohort landed in a "low gene count" group, and they were disproportionately the people with more adiposity, insulin resistance, dyslipidemia, and systemic inflammation; the pattern was especially visible among the obese participants, roughly 40% of whom fell in the low-richness group. The sharper detail: looking back over nine years of weight records, the low-richness group had gained more weight in the preceding years. That longitudinal twist gave the finding its gravity — it was not merely that heavier people currently had fewer species. As always with cohorts, the caveat rides along: low richness and poor metabolic health may share a common cause (a low-fiber diet) rather than one causing the other.
The Replication
The finding held up. In the Dutch LifeLines-DEEP cohort of 1,135 people, Zhernakova et al. (Science, 2016) catalogued 126 factors associated with microbiome composition — together explaining about 18.7% of the variation, with diet, medication use, and stool consistency among the strongest. The parallel Flemish study by Falony et al. (Science, 2016) landed on similar drivers and added a memorable detail: stool consistency and medication use — especially laxatives and acid-suppressing drugs — were among the very largest effects. The consistent story across cohorts: healthier dietary patterns, fewer drugs, and higher richness travel together. Meanwhile, the cross-population comparisons added a longer lens — children in rural Burkina Faso carried more species and more fiber-fermenting bacteria than European city children (De Filippo et al., PNAS, 2010), and Hadza hunter-gatherers in Tanzania cycle through seasonal richness swings that Western guts never experience (Smits et al., Science, 2017).
The Honest Limits
Diversity earned its reputation on association, and association is where its authority should stop. The specific limits worth internalizing:
- 🧭 No reference range exists. There is no clinically validated "healthy" Shannon value. Two healthy people can differ as much as a healthy and an unhealthy person on any given day.
- ↔️ Direction is unresolved. Richness may reflect health rather than produce it. The strongest experimental nudge — the Stanford fermented-foods trial (Wastyk et al., Cell, 2021) — raised diversity and lowered inflammatory markers in 36 adults, but whether that translates into fewer events over decades is untested.
- 🚽 Transit time confounds it. Stool consistency — which reflects how fast material moves — is one of the strongest single correlates of measured diversity (Falony et al., 2016). Some "diversity loss" may be plumbing, not ecology.
- 💊 Drugs dominate. Acid suppressors, laxatives, and antibiotics move richness more than most foods do — a reminder that a low score in someone on medication is not a dietary verdict.
📏 A score without a reference is a mirror, not a test
A commercial diversity percentile tells you how your sample compares to one company's other customers — not to health. It cannot diagnose, cannot set a target, and cannot tell you what to change. If curiosity is worth the price to you, enjoy the report; just don't let it drive decisions that diet trials have already settled. The levers with actual evidence — fiber, plant variety, fermented foods — work whether or not you measure them.
How to Move the Metric Without Measuring It
Everything below moves richness in the direction the cohort data reward, and each link goes to the page that owns the dose:
- 🌾 Fiber, in volume and variety. The highest-fiber consumers in the Lancet's pooled analyses showed 15–30% lower all-cause mortality, and fiber is the primary richness feedstock — see the Fiber topic for doses.
- 🥬 The 30-plant-points habit. Different plants feed different species; the Fiber & Fermented Foods topic turns variety into a countable weekly target.
- 🥒 Fermented foods. The Stanford trial's signal — more diversity, less inflammation — is moderate and short-term, but directionally right.
- 🚶 Exercise joins in. Fit adults carry measurably richer guts than matched sedentary peers in several cohorts — a modest, consistent add-on to the diet levers.
- 💊 And protect what you build. Antibiotics prune richness hard; recovery is real but slow — the Antibiotics & Recovery page covers the rebuild.
Questions, Answered Briefly
- 🧪 My test says "low diversity" — should I act? Treat it as a nudge toward the diet levers below, not a diagnosis. Without a validated reference range, the number cannot tell you how far you are from anything.
- 🌾 Does a fiber supplement fix it? A supplement adds one fiber type; the cohort evidence rewards many. Powder is a fine bridge — and it is not a substitute for plant variety.
- 💊 I take a daily acid-suppressing drug — is that tanking my score? Those drugs associate with altered composition, but do not stop a prescribed medication because of a stool test. If it concerns you, raise it with your clinician — that conversation is the intervention.
- 🚻 Does bowel habit matter for the score? More than people expect — transit time and stool consistency are among the strongest correlates of measured richness (Falony et al., 2016). Some "diversity loss" is slow plumbing, not missing species.
- 🥦 How fast can diet move the number? Composition shifts within days of a diet change; the kind of richness that marks healthy cohorts builds over months of consistent variety.
- 🧬 Is my baseline genetic? Heritability estimates for the microbiome are modest; environment and diet explain the larger share of differences between people — which is the optimistic finding.
The Bottom Line
- Diversity is the field's best-documented health correlate. Low richness clusters with adiposity, insulin resistance, and inflammation across large, replicated cohorts.
- It is a correlate, not a target. No trial has shown that raising a diversity score changes hard outcomes, and no reference range exists for "healthy."
- Diet, drugs, and transit time all move the number. The same factors that confound the metric are the ones worth acting on.
- Move it with food, not with tests. Fiber, plant variety, fermented foods, and exercise push richness in the healthy direction — measurement is optional, the diet is not.
Related Topics
- Le Chatelier et al., "Richness of human gut microbiome correlates with metabolic markers," Nature (2013)
- Zhernakova et al., "Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity," Science (2016)
- Falony et al., "Population-level analysis of gut microbiome variation," Science (2016)
- De Filippo et al., "Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa," PNAS (2010)
- Smits et al., "Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania," Science (2017)
- Yatsunenko et al., "Human gut microbiome viewed across age and geography," Nature (2012)
- Wastyk et al., "Gut-microbiota-targeted diets modulate human immune status," Cell (2021)
- Reynolds et al., "Carbohydrate quality and human health: a series of systematic reviews and meta-analyses," The Lancet (2019)